Latest News
Graphite Capital, a UK mid-market private equity specialist, has added to its team with the appointment of Simon May (pictured) as investment manager.
May joins Graphite after six years at PwC, most recently as a manager in the Business Recovery Services division where he focused on the manufacturing, distribution and healthcare sectors. He is a chartered accountant and holds a first class degree in mathematics from the University of Bath. As well as working with portfolio companies, May will look at investment opportunities and specifically cover the Midlands region.
Rod Richards, Graphite managing partner, says: “We are delighted to welcome
Global Capital Management’s Global Buyout Fund has successfully acquired 80% of Bıçakcılar Tıbbi Cihazlar AŞ and its group of companies (Bıçakcılar), the leading manufacturer of medical equipment and disposables, and distributor of cardiovascular and neurosurgery products in Turkey.
The agreement was signed by Ferhat Bıçakcı representing the owners, Bıçakcı Family and Ihsan Sancay, Partner at Global Capital Management in Turkey representing the Global Buyout Fund.
Bıçakcılar enjoys dominant market position in most of its product lines. It is the largest manufacturer of IV cannula in the Middle East and Eastern Europe and is the second largest manufacturer of
Cayman Finance Chairman Anthony Travers, OBE has stepped down from his post after two years in office.
According to Cayman Finance, Travers want to spend more time attending to his other business ventures and with his family. During this transitional period, the remaining board members will share directional responsibilities, and an interim Chairman is expected to be announced imminently. Further announcements will be made in due course.
“I was asked to take on the role at a time when our public relations were at a low ebb," says Travers. "At the time the UK and US Governments were extremely hostile to the Cayman
Ulthera, developer of the first-ever ultrasound device approved by the FDA for aesthetics, announced today the recent completion of USD10.5 million in Series C venture funding. The funding was led by New Enterprise Associates (NEA) with participation by funds managed by Apposite Capital LLP.
"Ulthera’s growth has been truly impressive, especially since receiving FDA clearance in late 2009," says Justin Klein, MD, Principal at New Enterprise Associates and Ulthera board member. "NEA looks to invest in companies that bring highly differentiated technologies to meet the needs of medical professionals and consumers, and we are enthusiastic about Ulthera’s future prospects. We
Rock Hill Capital Group has completed a recapitalization of Kiva Kitchen & Bath Holdings, LLC, a leading re-seller and installer of high-end household appliances, plumbing fixtures, hardware, countertops and cabinets. Kiva is headquartered in Houston, TX and sells through 12 showrooms located throughout Texas and Southern California.
Kiva was founded by Tolar N Hamblen and James A Cozby in 1998 and has grown through acquisition of local appliance retailers and organically by establishing long-term relationships with local builders/developers, architects and interior designers. Kiva’s annual revenues were approximately $80 million in 2010.
“We are pleased that Tolar and Jim selected Rock
Serge Adam has joined Highbridge Principal Strategies (HPS) as a Managing Director. Adam joins HPS after ten years at Sandell Asset Management, where he most recently was a senior managing director and portfolio manager for its credit business. He will share responsibility for managing the HPS public credit business with HPS Managing Director Purnima Puri.
“Serge is an exciting appointment to an already-strong team built by Purnima,” says Scott Kapnick (pictured), CEO of Highbridge Principal Strategies. “Serge’s experience managing complex hedged credit portfolios will be incredibly valuable as we take advantage of attractive opportunities in the credit markets, continue
Celtic Pharmaceutical Holdings, the global private equity firm focused on the biotechnology and pharmaceutical industries, has announced the presentation of key in-vitro data at the American Academy of Dermatology (AAD) 69th annual meeting in New Orleans (4-8 February, 2011) for TDT 067, terbinafine in Transfersomesâ, for the topical treatment of onychomycosis (also known as a fungal nail infection).
The first of the two in-vitro studies presented by the lead investigator, Professor Mahmoud Ghannoum, Director of the Centre for Medical Mycology at Case Western Reserve University in Cleveland, Ohio, investigates the actvity of TDT 067 against the common causative agents
Beringea, the international venture capital firm and manager of the ProVen VCTs, has sold its stake in Saffron Digital, a developer of video delivery platforms, to the HTC Corporation, a global designer of smartphones. In 2007 Beringea invested GBP1.15m in Saffron Digital through its ProVen VCT & ProVen Growth & Income VCT. The deal values the company at £30m and generated an IRR of 65%, on an investment return of 5.8x, for the two VCTs.
Trevor Hope, Beringea’s Chief Investment Officer, says: “We recognised some years ago the potential of mobile to drive digital media adoption and the great
Specialist fund services provider, Ipes has boosted its client base with the addition of two new mandates from private equity fund managers operating in the clean technology and renewable energy space.
The North West Energy and Environmental Fund, part of the North West Fund, which is largest public sector fund in the UK, has outsourced its back office administration to Ipes. The fund, which launched in December last year, is managed by CT Investment Partners and will make investments totalling GBP20m to support SMEs in the energy and environmental sector across the North West of England.
The North West
International law firm Mourant Ozannes has boosted its highly-ranked Cayman investment funds team with the recruitment of Simon Palmer, Robert Duggan and Caroline Spottiswoode.
Palmer is a leading practitioner in the field of offshore investment funds, with over 14 years’ experience of Cayman Islands law. He joins Mourant Ozannes as a Partner from Maples and Calder, where he was a Partner for seven years. Simon has extensive experience of corporate and commercial law. His practice focuses on hedge funds, private equity funds and funds of funds (including distressed funds, fund restructuring and corporate governance issues), asset and structured financing and capital
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
